AKT1 and neoplasm: Saiyang et al. [53] investigated tumor-educated B cells (TEBs) in KIRC and found that more TEBs were recruited in tumor tissues, which activated IL-1 to increase KIRC’s capacity for invasion and metastasis by triggering the PI3K/AKT pathway.